• The Latest Updated Products
  • Home > Product Partnering > The Latest Updated Products
Basic Search Search
The Latest Updated Products 게시물 리스트
product_code originator Lab Code or BRAND NAME API Action mechanism Indication Latest development stage Details
 PP100122004799   Vera Therapeutics, Inc.   VT-001   atacicept   An anti-Bl..   IgA nephro..   Phase III, Phase III    View Details 
 PP090113005630   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   Estybon IV, ON01910-Na   rigosertib sodium   A polo-lik..   2nd line h..   Phase III, Preclinical completed, Preclinical completed    View Details 
 PP090113005631   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   Estybon Oral, ON01910-Na   rigosertib sodium   A polo-lik..   1st line l..   Phase II, Phase II, Preclinical completed, Preclinical completed    View Details 
 PP090320006133   VistaGen Therapeutics, Inc. (since Feb 2023), Pherin Pharmaceuticals, Inc.   Aloradine, PH94B   4-androstadienol; 4,16-androstadien-3β-ol; fasedienol   A potent p..   Social anx..   Phase III    View Details 
 PP090320006134   VistaGen Therapeutics, Inc. (since Feb 2023), Pherin Pharmaceuticals, Inc.   PH284         Wasting sy..   Phase II    View Details 
 PP090320006135   VistaGen Therapeutics, Inc. (since Feb 2023), Pherin Pharmaceuticals, Inc.   PH15         Cognitive ..   Phase II, Phase II    View Details 
 PP090320006136   VistaGen Therapeutics, Inc. (since Feb 2023), Pherin Pharmaceuticals, Inc.   PH10   itruvone   A chemorec..   Major depr..   Phase II    View Details 
 PP090923006286   Vivoryon Therapeutics AG (since Jun 2019), Probiodrug AG   PQ912   varoglutamstat   Inhibition..   Diabetic k..   Phase II completed, Phase II    View Details 
 PP090323007715   Vanda Pharmaceuticals Inc.   Hetlioz®, VEC-162   tasimelteon   A dual mel..   Non-24-hou..   Approved, NDA, NDA    View Details 
 PP120713009948   Traws Pharma, Inc.(since Apr 2024), Onconova Therapeutics Inc.   ON123300, HX301   narazaciclib   A dual inh..   Metastatic..   Phase II, Phase II    View Details